Total raised
$70.1M
Last stage
Series C
Investors
Melanie Matheu
Dr. Matheu co-founded Prellis Biologics in 2016. An expert in laser-based imaging of the immune system, she developed the company's core platform technology using her PhD work in laser microscopy, cell biology, and biophysics. She previously served as CEO before transitioning to CTO.
LinkedInNoelle Huskey Mullin
Co-founded Prellis Biologics in 2016 alongside Dr. Melanie Matheu.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.